SIMULATIONS PLUS INC (SLP) Stock News
NASDAQ:SLP - Nasdaq - US8292141053 - Common Stock - Currency: USD
SLP Latest News, Press Relases and Analysis
All
Press Releases
18 days ago - Simulations Plus, Inc.
Simulations Plus to Participate in Upcoming Healthcare Investor Conferences
a month ago - Simulations Plus, Inc.
Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements
a month ago - Simulations Plus, Inc.
Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024
2 months ago - Simulations Plus, Inc.
Simulations Plus Reports First Quarter Fiscal 2025 Financial Results
2 months ago - Simulations Plus, Inc.
Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date
3 months ago - Simulations Plus, Inc.
Simulations Plus to Participate in the BTIG Digital Health Forum
3 months ago - Simulations Plus, Inc.
Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables
4 months ago - Simulations Plus, Inc.
Simulations Plus to Participate in the Stephens Annual Investment Conference
4 months ago - Simulations Plus, Inc.
Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations
4 months ago - Simulations Plus, Inc.
Simulations Plus Reports Fourth Quarter and Fiscal 2024 Financial Results
5 months ago - Simulations Plus, Inc.
Simulations Plus Announces Fourth Quarter and Fiscal Year 2024 Earnings and Conference Call Date
8 months ago - BusinessInsider
SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q3 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Simulations Plus (NASDAQ:SLP) just reported results for the third quarter of 20...
5 months ago - Simulations Plus, Inc.
Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings
6 months ago - Simulations Plus, Inc.
Simulations Plus to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
6 months ago - Simulations Plus, Inc.
Simulations Plus Optimizes Business Unit Structure to Support Future Growth Following Recent Strategic Acquisitions
7 months ago - Simulations Plus, Inc.
Simulations Plus Releases DILIsym® X
7 months ago - Simulations Plus, Inc.
Simulations Plus Releases ADMET Predictor® Version 12
7 months ago - Simulations Plus, Inc.
Simulations Plus to Participate in KeyBanc’s 25th Annual Technology Leadership Forum
8 months ago - Simulations Plus, Inc.
Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety
8 months ago - InvestorPlace
SLP Stock Earnings: Simulations Plus Beats EPS, Beats Revenue for Q3 2024
SLP stock results show that Simulations Plus beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
8 months ago - Simulations Plus, Inc.